Name and surname:
|
RNDr. Michaela Čeháková, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
assistant lecturer, research scientist | Institute of Medical Biology, Genetics, and Clinical Genetics, Faculty of Medicine, Comenius University | 1.7.2023-30.6.2024, 1.3.2022-30.6.2025 |
Research Scientist | National Institute of Rheumatic Diseases, Nábrežie I. Krasku č. 4, 921 12 Piešťany | 07/2020-05/2023 |
Project Management Analyst | IQVIA RDS Slovakia, Vajnorská 100/B, 831 04 Bratislava | 08/2019-06/2020 |
Laboratory Diagnostician | Medirex, a.s., Galvaniho 17/C, 820 16 Bratislava | 04/2018-07/2019 |
PostDoctoral Research Scientist | Institute of Virology, Biomedical Research Centre, SAS, Dúbravská cesta 9, 845 05 Bratislava | 06/2016-04/2018 |
Cehakova M, Ivanisova D, Strecanska M, Plava J, Varchulova Novakova Z, Nicodemou A, Harsanyi S, Culenova M, Bernatova S, Danisovic L. Rheumatoid Synovial Fluid and Acidic Extracellular pH Modulate the Immunomodulatory Activity of Urine-Derived Stem Cells. Int J Mol Sci. 2023 Nov 1;24(21):15856. doi: 10.3390/ijms242115856. PMID: 37958839; PMCID: PMC10648750.
Nicodemou A, Bernátová S, Čeháková M, Danišovič Ľ. Emerging Roles of Mesenchymal Stem/Stromal-Cell-Derived Extracellular Vesicles in Cancer Therapy. Pharmaceutics. 2023 May 10;15(5):1453. doi: 10.3390/pharmaceutics15051453. PMID: 37242693; PMCID: PMC10221697.
Strecanska M, Danisovic L, Ziaran S, Cehakova M. The Role of Extracellular Matrix and Hydrogels in Mesenchymal Stem Cell Chondrogenesis and Cartilage Regeneration. Life (Basel). 2022 Dec 9;12(12):2066. doi: 10.3390/life12122066. PMID: 36556431; PMCID: PMC9784885.
Csöbönyeiová M, Beerová N, Klein M, Debreová-Čeháková M, Danišovič Ľ. Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options? Int J Mol Sci. 2022 Sep 7;23(18):10314. doi: 10.3390/ijms231810314. PMID: 36142245; PMCID: PMC9499607.
Debreova M, Culenova M, Smolinska V, Nicodemou A, Csobonyeiova M, Danisovic L. Rheumatoid arthritis: From synovium biology to cell-based therapy. Cytotherapy. 2022 Apr;24(4):365-375. doi: 10.1016/j.jcyt.2021.10.003. Epub 2022 Jan 26. PMID: 35090806.
Culenova M, Nicodemou A, Novakova ZV, Debreova M, Smolinská V, Bernatova S, Ivanisova D, Novotna O, Vasicek J, Varga I, Ziaran S, Danisovic L. Isolation, Culture and Comprehensive Characterization of Biological Properties of Human Urine-Derived Stem Cells. Int J Mol Sci. 2021 Nov 19;22(22):12503. doi: 10.3390/ijms222212503. PMID: 34830384; PMCID: PMC8624597.
Cehakova M, Ivanisova D, Strecanska M, Plava J, Varchulova Novakova Z, Nicodemou A, Harsanyi S, Culenova M, Bernatova S, Danisovic L. Rheumatoid Synovial Fluid and Acidic Extracellular pH Modulate the Immunomodulatory Activity of Urine-Derived Stem Cells. Int J Mol Sci. 2023 Nov 1;24(21):15856. doi: 10.3390/ijms242115856. PMID: 37958839; PMCID: PMC10648750.
Nicodemou A, Bernátová S, Čeháková M, Danišovič Ľ. Emerging Roles of Mesenchymal Stem/Stromal-Cell-Derived Extracellular Vesicles in Cancer Therapy. Pharmaceutics. 2023 May 10;15(5):1453. doi: 10.3390/pharmaceutics15051453. PMID: 37242693; PMCID: PMC10221697.
Strecanska M, Danisovic L, Ziaran S, Cehakova M. The Role of Extracellular Matrix and Hydrogels in Mesenchymal Stem Cell Chondrogenesis and Cartilage Regeneration. Life (Basel). 2022 Dec 9;12(12):2066. doi: 10.3390/life12122066. PMID: 36556431; PMCID: PMC9784885.
Csöbönyeiová M, Beerová N, Klein M, Debreová-Čeháková M, Danišovič Ľ. Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options? Int J Mol Sci. 2022 Sep 7;23(18):10314. doi: 10.3390/ijms231810314. PMID: 36142245; PMCID: PMC9499607
Debreova M, Culenova M, Smolinska V, Nicodemou A, Csobonyeiova M, Danisovic L. Rheumatoid arthritis: From synovium biology to cell-based therapy. Cytotherapy. 2022 Apr;24(4):365-375. doi: 10.1016/j.jcyt.2021.10.003. Epub 2022 Jan 26. PMID: 35090806.
Culenova M, Nicodemou A, Novakova ZV, Debreova M, Smolinská V, Bernatova S, Ivanisova D, Novotna O, Vasicek J, Varga I, Ziaran S, Danisovic L. Isolation, Culture and Comprehensive Characterization of Biological Properties of Human Urine-Derived Stem Cells. Int J Mol Sci. 2021 Nov 19;22(22):12503. doi: 10.3390/ijms222212503. PMID: 34830384; PMCID: PMC8624597.
Sun H, Guo Y, Wang H, Yin A, Hu J, Yuan T, Zhou S, Xu W, Wei P, Yin S, Liu P, Guo X, Tang Y, Yan Y, Luo Z, Wang M, Liang Q, Wu P, Zhang A, Zhou Z, Chen Y, Li Y, Li J, Shan J, Zhou W. Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. Gut. 2023 Sep;72(9):1664-1677. doi: 10.1136/gutjnl-2022-327756. Epub 2023 Jan 5. PMID: 36604114.
Chang TH, Wu CS, Chiou SH, Chang CH, Liao HJ. Adipose-Derived Stem Cell Exosomes as a Novel Anti-Inflammatory Agent and the Current Therapeutic Targets for Rheumatoid Arthritis. Biomedicines. 2022 Jul 18;10(7):1725. doi: 10.3390/biomedicines10071725. PMID: 35885030; PMCID: PMC9312519.
Liu P, Mao Y, Xie Y, Wei J, Yao J. Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential. Stem Cell Res Ther. 2022 Jul 26;13(1):356. doi: 10.1186/s13287-022-03041-5. PMID: 35883127; PMCID: PMC9327386.
Huang RL, Li Q, Ma JX, Atala A, Zhang Y. Body fluid-derived stem cells - an untapped stem cell source in genitourinary regeneration. Nat Rev Urol. 2023 Dec;20(12):739-761. doi: 10.1038/s41585-023-00787-2. Epub 2023 Jul 6. PMID: 37414959.
2023 – 2026 Principal investigator VEGA (1/0281/23): The effect of various environmental stress factors on improvement of the biological potential of mesenchymal stromal cells for application in autologous therapy and tissue engineering
The mesenchymal stromal cells (MSC) application shows promising results, therefore intensive research is currently underway generating outputs for cell therapies and tissue engineering. Even if MSC have low immunogenicity autologous cells are still preferred in clinical practice. The MSC biological properties are compromised with advanced age as well as disease status of the donor. Aged individuals often with advanced disease stages are target population for cell-based therapies/regeneration of damaged tissues. It is therefore essential to develop effective strategies to stimulate the impaired biological potential of autologous MSC. Thus, the presented project focuses on the comprehensive characterization of various approaches of external MSC stimulation (hypoxia, heat shock, etc.) leading to an increase in their biological activity for application in cell-based therapy. It also analyzes the behavior of stimulated MSC after seeding on scaffold (in vitro and in vivo) for potential use in tissue engineering.
2020 – 2023 Co-investigator: Biobank for cancer and rare diseases (ITMS2014+: 313011AFG5)
The project is entirely oriented towards building a modern, efficient and systematic method of biobanking in Slovakia, which represents one of the basic pillars of excellent biomedical research.
Due to the fact that this is a project with strategic importance in the field of biomedicine, academic workplaces, research centers and parks and health institutions that have biomedicine in their programs were integrated into the project, and it is assumed that the highest quality scientific and research capacities with sufficient infrastructural security. In all its specific objectives, the project supports the integration, optimization and further development of research infrastructure, including international scientific and technical cooperation, which is a key element in the implementation of individual project activities.